Anaemia and heart failure: Statement of the problem

Nephrology Dialysis Transplantation

Volumn 20, Issue SUPPL. 7, 2005, Pages

  Lewis, Basil S ^a   Karkabi, Basheer ^a   Jaffe, Ronen ^a   Yuval, Rita ^a   Flugelman, Moshe Y ^a   Halon, David A ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

Anaemia; Erythropoietin; Heart failure; Iron deficiency; Renal failure

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; IRON; PLACEBO;

ANEMIA; ARTICLE; BLEEDING; BONE MARROW DEPRESSION; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG CHOICE; HEALTH STATUS; HEART CONTRACTION; HEART FAILURE; HEART INJURY; HEART VENTRICLE FUNCTION; HEMODILUTION; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITALIZATION; HUMAN; IRON DEFICIENCY; KIDNEY DISEASE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; SYSTOLE; VITAMIN DEFICIENCY; WELLBEING;

ADULT; AGED; AGED, 80 AND OVER; ANEMIA; ERYTHROPOIETIN; HEART FAILURE; HUMANS; IRON; MIDDLE AGED; PREVALENCE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 27144488673     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh1099     Document Type: Article

References (32)

1. Swedberg K, Kjekshus J. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). Am J Cardiol 1988; 62: 60A-66A
2. The MERIT-HF Investigators. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-2007
3. Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35: 1737-1744
4. Silverberg DS, Wexler D, Sheps D et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-1780
5. Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 2002; 4: 681-686
6. Silverberg D, Wexler D, Blum M et al. The cardio-renal anaemia syndrome: does it exist? Nephrol Dial Transplant 2003; 18 [Suppl 8]: VIII7-VIII12
7. Silverberg DS, Wexler D, Blum M et al. Erythropoietin should be part of congestive heart failure management. Kidney Int Suppl 2003; 64: S40-S47
8. Cleland JG, Swedberg K, Follath F et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003; 24: 442-463
9. Steinborn W, Doehner W, Anker SD. Anemia in chronic heart failure - frequency and prognostic impact. Clin Nephrol 2003; 60 [Suppl 1]: S103-S107
10. Androne AS, Katz SD, Lund L et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107: 226-229
11. Lewis BS, Gotsman MS. Current concepts of left ventricular relaxation and compliance. Am Heart J 1980; 99: 101-112
12. Rakusan K, Cicutti N, Kolar F. Effect of anemia on cardiac function, microvascular structure, and capillary hematocrit in rat hearts. Am J Physiol 2001; 280: H1407-H1414
13. Gaasch WH. Left ventricular radius to wall thickness ratio. Am J Cardiol 1979; 43: 1189-1194
14. Frohlich ED, Apstein C, Chobanian AV et al. The heart in hypertension. N Engl J Med 1992; 327: 998-1008
15. Singh PI, Verma K, Sood S. Noninvasive evaluation of left ventricular function in chronic severe anemia. Jpn Heart J 1989; 30: 129-136
16. Bahl VK, Malhotra OP, Kumar D et al. Noninvasive assessment of systolic and diastolic left ventricular function in patients with chronic severe anemia: A combined M-mode, two-dimensional, and Doppler echocardiographic study. Am Heart J 1992; 124: 1516-1523
17. Hayashi R, Ogawa S, Watanabe Z et al. Cardiovascular function before and after iron therapy by echocardiography in patients with iron deficiency anemia. Pediatr Int 1999; 41: 13-17
18. Alvares JF, Oak JL, Pathare AV. Evaluation of cardiac function in iron deficiency anemia before and after total dose iron therapy. J Assoc Physicians India 2000; 48: 204-206
19. Horwich TB, Fonarow GC, Hamilton MA et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-1786
20. Szachniewicz J, Petruk-Kowalczyk J, Majda J et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003; 90: 303-308
21. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: The prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 2003; 41: 1933-1939
22. Felker GM, Gattis WA, Leimberger JD et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 2003; 92: 625-628
23. Pereira AA, Sarnak MI. Anemia as a risk factor for cardiovascular disease. Kidney Int Suppl 2003; 64: S32-S39
24. Kalra, PR, Collier T, Cowie MR et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet 2003; 362: 211-212
25. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223-225
26. Kosiborod M, Smith GL, Radford MJ et al. The prognostic importance of anemia in patients with heart failure. Am J Med 2003; 114: 112-119
27. Kalra PR, Bolger AP, Francis DP et al. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 2003; 91: 888-891
28. Mancini DM, Katz SD, Lang CC et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107: 294-299
29. Smith KJ, Bleyer AJ, Little WC et al. The cardiovascular effects of erythropoietin. Cardiovasc Res 2003; 59: 538-548
30. Bahlmann FH, DeGroot K. Duckert T et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int 2003; 64: 1648-1652
31. Bahlmann FH, De Groot K, Spandau JM et al. Erythropoietin regulates endothelial progenitor cells. Blood 2004; 103: 921-926
32. Gregory DD, Sarnak MJ, Konstam MA et al. Impact of chronic kidney disease and anemia on hospitalization expense in patients with left ventricular dysfunction. Am J Cardiol 2003; 92: 1300-1305